Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL By Ogkologos - December 12, 2024 662 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR FDA Approves Safety Labelling Changes Regarding DPD Deficiency for Fluorouracil Injection... April 19, 2024 How Financial Toxicity Can Impact Cancer Caregivers and Where to Find... August 23, 2022 New Cancer Model Shows Promise in Predicting If Treatment Will Shrink... July 28, 2022 FDA Approves Pralsetinib for Non-Small Cell Lung Cancer with RET Gene... September 1, 2023 Load more HOT NEWS Blinatumomab Improves Survival in Children with Relapsed Leukemia A Pet Pug Helped Two Sisters Realize They Both Had Breast... What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials Mom Is Outraged After Finding Out Her Mother-In-Law Changed The Baby’s...
